Health Minister Hala Zayed has agreed to look into repricing 330 meds manufactured by state-owned companies, Public Enterprises Minister Hisham Tawfik tells Al Mal. According to Tawfik, the repricing will not necessarily entail an increase in the retail price, and will assess possible scenarios to reduce manufacturing costs. He did note that some of these meds are currently being sold at less than their cost of production. This comes as private pharma companies are also pushing to raise med prices, saying the most recent increases in fuel prices and electricity tariffs, along with a global rise in the cost of raw materials made raising med prices a necessity.